课题基金 / 基金详情

Validation of the human geranylgeranyl pyrophosphate synthase (hGGPPS) as a therapeutic target for cancer chemotherapy and design of pre-clinical candidates for the treatment of multiple myeloma

Validation of the human geranylgeranyl pyrophosphate synthase (hGGPPS) as a therapeutic target for cancer chemotherapy and design of pre-clinical candidates for the treatment of multiple myeloma
验证人香叶基香叶基焦磷酸合酶 (hGGPPS) 作为癌症化疗的治疗靶点,并设计治疗多发性骨髓瘤的临床前候选药物
批准号:
380326
负责人:
Tsantrizos Youla S
金额:
$64.34万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2018
资助国家:
加拿大
项目状态:
已结题
起止时间:
2018-03-01 至 2023-03-01

项目摘要

项目成果

Tsantrizos Youla S的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The human enzyme geranylgeranyl pyrophosphate synthase (hGGPPS) is responsible for the biosynthesis of the metabolite geranylgeranyl pyrophosphate (GGPP), which plays an important role in activating proteins involved in cancer progression. Recent biochemi
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Molecular Tools that Block Maturation of the Nuclear Lamin A, Leading to Decrease in Proliferation and Metastasis of Pancreatic Ductal Adenocarcinoma and Colorectal Cancer
  • 批准号:
    461368
  • 项目类别:
    Operating Grants
  • 资助金额:
    $78.02万
  • 财政年份:
    2022
  • 负责人:
    Tsantrizos Youla S
  • 依托单位:
Benchmark proprietary pyridine- and thienopyrimidine-based bisphosphonates against the standard of care drug Zometa® in the treatment of multiple myeloma
  • 批准号:
    293953
  • 项目类别:
    Operating Grants
  • 资助金额:
    $11.66万
  • 财政年份:
    2013
  • 负责人:
    Tsantrizos Youla S
  • 依托单位:
Validation of the human farnesyl pyrophosphate synthase (hFPPS) as a therapeutic target and design of pre-clinical candidates for the treatment of multiple myeloma and neurodegenerative diseases.
  • 批准号:
    265657
  • 项目类别:
    Operating Grants
  • 资助金额:
    $51.28万
  • 财政年份:
    2012
  • 负责人:
    Tsantrizos Youla S
  • 依托单位:
海外基金